Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

KALLESTAD QM300 PROTEIN ANALYSIS SYSTEM

K-Number: K871339 · 1987-05-15

ApplicantKallestad Diag, A Div. of Erbamont, Inc.
Decision Date1987-05-15
Product CodeJQP
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

KALLESTAD QM300 PROTEIN ANALYSIS SYSTEM is the device name listed in this FDA 510(k) record. The listed applicant is Kallestad Diag, A Div. of Erbamont, Inc.. It received FDA 510(k) clearance on 1987-05-15 under 510(k) number K871339. The device is classified under product code JQP. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the KALLESTAD QM300 PROTEIN ANALYSIS SYSTEM?

KALLESTAD QM300 PROTEIN ANALYSIS SYSTEM is a medical device that received FDA 510(k) clearance on 1987-05-15. The listed applicant is Kallestad Diag, A Div. of Erbamont, Inc.. The 510(k) number is K871339.

When did KALLESTAD QM300 PROTEIN ANALYSIS SYSTEM receive FDA 510(k) clearance?

KALLESTAD QM300 PROTEIN ANALYSIS SYSTEM received FDA 510(k) clearance on 1987-05-15, under 510(k) number K871339.

Who is the listed applicant for KALLESTAD QM300 PROTEIN ANALYSIS SYSTEM?

The FDA 510(k) record lists Kallestad Diag, A Div. of Erbamont, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for KALLESTAD QM300 PROTEIN ANALYSIS SYSTEM?

The FDA product code for KALLESTAD QM300 PROTEIN ANALYSIS SYSTEM is JQP.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Kallestad Diag, A Div. of Erbamont, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K910887QM300 CONTROL G PACKK910886QM300 ANTISTREPTOLYSIN O (ASO) ANTIGEN PACKK910885QM300 CALIBRATOR G PACKK904725CHLAMYDIA SYSTEM SOFTWARE (CSS)K902253PATHFINDER(TM) CHLAMYDIA MICROPLATE KITK902462MODIFIED QM300 RHEUMATOID FACTOR TEST

View all 58 devices →

Related Devices (Code: JQP)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K113007BIONIME DIABETES MANAGEMENT SYSTEM VI.0Bionime CorporationK983468FASTTAKE ADAPTER, MODEL # P/N 020-072-01Selfcare, Inc.K964460THE ROBOLITEShai Syg Motion and Innovations, Ltd.K953652PRENVAL IBase Ten Systems, Inc.K934111MR7000 WITH TIME MANAGER SOFTWARE (TMS)Dynatech Laboratories, Inc.K923316EXPRESSO CARTRIDGEBio-Rad Laboratories, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑